Current status and perspectives of individualized therapy for non-small cell lung cancer based on molecular targeting.
10. 3760/cma.j.issn.0253-3766.2012.05.019
- Author:
Yuan-kai SHI
- Publication Type:Journal Article
- MeSH:
Animals;
Antibodies, Monoclonal;
Carcinoma, Non-Small-Cell Lung;
drug therapy;
Crown Ethers;
therapeutic use;
Drug Resistance, Neoplasm;
Erlotinib Hydrochloride;
Humans;
Immunoglobulins, Intravenous;
therapeutic use;
Lung Neoplasms;
drug therapy;
Molecular Targeted Therapy;
Mutation;
Precision Medicine;
Protein Kinase Inhibitors;
therapeutic use;
Pyrazoles;
therapeutic use;
Pyridines;
therapeutic use;
Quality Control;
Quinazolines;
therapeutic use;
Receptor, Epidermal Growth Factor;
antagonists & inhibitors;
genetics
- From:
Chinese Journal of Oncology
2012;34(5):398-400
- CountryChina
- Language:Chinese
